您的位置: 专家智库 > >

国家自然科学基金(30801502)

作品数:17 被引量:194H指数:8
相关作者:王凌李大金邱学敏孙婵李丽莎更多>>
相关机构:复旦大学复旦大学上海医学院上海中医药大学更多>>
发文基金:国家自然科学基金上海市浦江人才计划项目上海市教育委员会重点学科基金更多>>
相关领域:医药卫生更多>>

文献类型

  • 17篇期刊文章
  • 1篇会议论文

领域

  • 18篇医药卫生

主题

  • 6篇细胞
  • 6篇激素
  • 6篇雌激素
  • 5篇骨质
  • 5篇骨质疏松
  • 4篇骨质疏松症
  • 3篇代谢
  • 3篇调节性
  • 3篇趋化
  • 3篇趋化因子
  • 3篇免疫
  • 3篇节性
  • 3篇绝经后骨质疏...
  • 3篇绝经后骨质疏...
  • 3篇激素缺乏
  • 3篇骨代谢
  • 3篇骨细胞
  • 3篇CHINES...
  • 3篇雌激素缺乏
  • 2篇蛋白

机构

  • 8篇复旦大学
  • 7篇复旦大学上海...
  • 1篇海南医学院附...
  • 1篇上海中医药大...

作者

  • 13篇王凌
  • 5篇邱学敏
  • 5篇李大金
  • 2篇孙婵
  • 1篇罗成燕
  • 1篇李翠
  • 1篇段忠亮
  • 1篇王菲菲
  • 1篇李丽莎
  • 1篇张娜
  • 1篇王菲菲
  • 1篇王菲菲

传媒

  • 3篇中国免疫学杂...
  • 3篇Chines...
  • 2篇老年医学与保...
  • 2篇现代免疫学
  • 1篇生殖医学杂志
  • 1篇中国中西医结...
  • 1篇中医杂志
  • 1篇中华内分泌代...
  • 1篇Journa...
  • 1篇Cellul...
  • 1篇中华生殖与避...
  • 1篇第9届中国中...

年份

  • 1篇2020
  • 3篇2019
  • 2篇2018
  • 5篇2017
  • 2篇2016
  • 1篇2015
  • 1篇2013
  • 2篇2011
  • 1篇2009
17 条 记 录,以下是 1-10
排序方式:
A General Description for Chinese Medicine in Treating Premature Ovarian Failure被引量:42
2017年
Premature ovarian failure(POF) is a kind of gynecological disease that causes amenorrhea, infertility, menopause and urogenital symptoms. Currently hormone replacement therapy(HRT) is the most popular choice for women with POF to get rid of menopausal syndrome. However, as the popularization of Chinese herbs made Chinese medicine(CM) shine new lights, physicians are able to treat POF with both meno-herbs and integrated therapy. HRT has its own indications and contraindications. For example, unexplained vaginal bleeding, acute liver damage, liver dysfunction, vascular embolization, and breast cancer are all contraindications of HRT, and CM is taken by more physicians as an adjuvant therapy. This review, including a range of common Chinese herbs and formulations according to the existing literature, provides a general description of CM treating POF from the aspects of mechanisms and clinical application. It also highlights acupuncture as a unique physiotherapy for POF. Although the validity of CM has been supported by the evidence of many preclinical trials, clinical trials and meta-analysis, the adverse events with CM therapy still exist and no guarantee has been made for its safety. This review concludes the updated information for CM treating POF contributing to further studies.e
LIN JingLI Xue-lianSONG HuiLI QianWANG Ming-yanQIU Xue-minLI Da-jinWANG Ling
载脂蛋白E调控骨代谢的研究进展被引量:1
2015年
骨质疏松症和动脉粥样样硬化是老年人群中的常见病和多发病。近年来,大量研究表明这两种退行性疾病之间存在密切联系。血脂异常是动脉粥样硬化的显著特征也常见于骨质疏松症患者,脂代谢紊乱可能是这两种疾病潜在的共同发病原因之一[1]。脂蛋白转运脂质是脂代谢的中心环节,受到位于细胞表面的脂蛋白受体调节[2]。脂蛋白的重要组成成分载脂蛋白E(Apolipoprotein E,ApoE)是脂蛋白受体的配体,在脂代谢中扮演重要角色[3]。探讨ApoE对骨代谢的调控作用,有助于揭示联系脂代谢与骨代谢的分子机制,为诊断和治疗骨代谢相关疾病提供新思路。
桂玉燕邱学敏许莹萍王凌
关键词:载脂蛋白E骨代谢脂代谢紊乱骨质疏松症退行性疾病代谢相关疾病
Chinese Medicine as Complementary Therapy for Female Infertility被引量:15
2017年
Chinese medicine (CM) has been used in clinical treatment for thousands of years in China, Japan, Korea, and other countries. CM is at present attracting many attentions around the world for reproductive health care and disease prevention, including treatment of female infertility. This review focuses on the CM treatment for female infertility patients, and supplies a summary on the efficacy, safety, and mechanism of some Chinese herbal medicines, herbal medicine-derived active compounds, and acupuncture. A large number of researches have reported that CM could alleviate or even cure female infertility by regulating hormone, improving reproductive outcome of in vivo fertilization, affecting embryonic implantation, curing polycystic ovarian syndrome, endometriosis, pelvic inflammatory disease, relieving mental stress, and regulating immune system. Meanwhile, a few studies claimed that there was little adverse reaction of CM in randomized controlled trials. However, up to present there is a lack of adequate evidences with molecular mechanistic researches and randomized controlled trials to prove the CM as an effective and safe treatment for infertility. Thus, utility of CM as a complementary medicine will be a feasible method to improve the outcome of female infertility treatment.
XIA du-fengYoshinori InagakiZHANG Jian-fengWANG LingSONG Pei-pei
复发性流产患者CD4^+T细胞及调节性T细胞上T细胞免疫球蛋白和免疫受体酪氨酸抑制基序的表达被引量:3
2019年
目的探讨CD4^+T细胞及调节性T(Treg)细胞上T细胞免疫球蛋白和免疫受体酪氨酸抑制基序(T cell immunoglobulin and immunorecep tortyrosine-based inhibitory motif domain,TIGIT)与复发性流产(RSA)发病的关系。方法采用前瞻性病例-对照研究收集2017年7月—2018年8月期间在复旦大学附属妇产科医院的60例RSA患者(RSA组)和68例相同孕周正常早孕者(对照组)的外周血。采用流式细胞术检测抗凝外周血中CD4^+T细胞及Treg细胞上表面分子TIGIT的百分含量。结果CD4+T细胞在外周血中的比例组间比较差异无统计学意义,且TIGIT^+CD4^+T细胞的比例组间差异也无统计学意义(P>0.05);Treg细胞在RSA组外周血中的比例低于对照组(P=0.02);但RSA组TIGIT^+FoxP3^+CD4^+T细胞所占比例为56.41%±12.36%,高于对照组中的表达(47.82%±10.53%),差异有统计学意义(P=0.03)。结论TIGIT在RSA患者外周血Treg细胞上的表达异常升高,提示其与RSA的发生可能相关。
梁昀段忠亮李翠李大金王凌
关键词:复发性流产调节性T细胞CD4^+T细胞
绝经后骨质疏松症中医药研究进展被引量:32
2019年
绝经后骨质疏松症(postmenopausal osteoporosis,PMO)是指由绝经后雌激素及相关内分泌改变引起的骨量减少、骨微结构受损、骨强度降低,导致骨脆性增加为特征的骨代谢性疾病,女性在50岁后患病率明显增加。主要临床表现为周身疼痛,相应运动如翻身、起坐等受限,影响生活质量。除此以外,严重时还可导致骨骼变形、身高降低及脆性骨折等。
潘心瑶谢欣薇周琦陈兰婷王凌
关键词:骨吸收功能PMO龟鹿二仙胶二仙汤雌激素缺乏
肠道微生态影响绝经后骨质疏松症发生发展的研究进展被引量:11
2019年
肠道微生物的数量是人类细胞数的数十倍,可以被看成人体的一种器官,以多种方式与宿主相互作用并影响宿主;它包含的基因数远远超过人类的基因数,被称为人体的“第二基因组”;它可以影响宿主组织(如骨组织)的发育和稳态。绝经后骨质疏松症是一种在绝经后妇女中高发的疾病,是指绝经后妇女由于卵巢衰退,雌激素水平下降导致骨吸收大于骨形成,出现以骨量降低和骨组织的显微结构退行性变为特征、骨脆性和骨折易感性增加的一种全身代谢疾病。女性雌激素衰退是绝经后骨质疏松症发生的重要诱因,而肠道微生物在性激素缺乏引起骨质流失的发生中处于中心地位。肠道微生物通过宿主的免疫系统调控骨代谢;雌激素缺乏导致的肠壁通透性增加会引起细菌移位和增强机体的炎症反应,而肠道益生菌可以通过抑制炎症反应和增强肠道上皮的屏障功能来防止骨质流失。肠道微生物亦可通过机体的代谢来调节骨代谢,短链脂肪酸是益生元发酵的主要产物,它能诱导IGF-1的产生,增加骨量。肠道微生物还可以通过增强营养物质摄取、合成人体必需营养物质从而改善机体的营养状况的方式来影响骨代谢。
李丽娟林静王凌
关键词:肠道微生物绝经后骨质疏松症免疫反应
Effects of Heyan Kuntai Capsule(和颜坤泰胶囊)on Follicular Development and Oocyte Cohesin Levels in Aged Mice被引量:8
2018年
Objective: To evaluate the effect of Heyan Kuntai Capsule (和颜坤泰胶囊, HYKT) on the ovarian function of aged mice and expressions of cohesion complexes in oocytes. Methods: Twenty-five 9-month-old female C57BL/6J mice were randomly divided into 5 groups by block randomization method (n=5 per group), including the control group (saline), 17β-estradiol group [E2, 100 μg/(kg·d)], and low-, medium-, and high- dose of HYKT groups [0.3, 0.9, 2.7 g/(kg·d), respectively]. All mice were treated by intragastric administration for 4 weeks. Hematoxylin and eosin staining and anti-VASA staining were used to detect the amounts of follicles. The apoptosis of follicles was measured by anti-gamma H2A histone family member X (γ, H2AX) staining and TdT-mediated dUTP Nick-End Labeling (TUNEL) assay. The density of cohesin subunits, REC8 meiotic recombination protein (REC8), structural maintenance of chromosome (SMC) 1 β and SMC3 in oocytes were evaluated by immunofluorescent staining. Results: After administration of E2 and high-dose of HYKT, the total number of follicles as well as the number of primordial and primary follicles were significantly increased (P〈0.05). Anti-γ/H2AX staining and TUNEL assay demonstrated that high-dose of HYKT and E2 partly suppressed the apoptosis of follicles (P〈0.05). Furthermore, it showed an increased trend in the levels of REC8 and SMC1 β, after administration with E2 and HYKT, and no obvious change in the level of SMC3. Conclusion: HYKT could enhance the number of follicles, suppress apoptosis of oocytes and have a trend to elevate the meiotic-specific cohesin subunits (REC8 and SMC1 β) in oocytes of aged mice, indicating a beneficial effect on the ovarian function in terms of the quantity and quality of follicles.
ZHANG BinCHU NanQIU Xue-minTANG WeiHans-Jorgen GoberLI Da-jinWANG Ling
关键词:COHESINOOCYTE
CD4^+T细胞在绝经后骨质疏松症发病机制中的调控作用被引量:6
2016年
绝经后骨质疏松症(Postmenopausal osteoporosis,PMO)是绝经后女性的常见病,是导致绝经后女性骨折的主要原因,研究表明骨质疏松性骨折的发病率很高,仅在美国每年就有150万例发生,同时骨折使各种并发症发生风险增加,如帕金森病、多发性硬化症、肺和心脏等疾病。
许莹萍邱学敏桂玉燕张娜王凌
关键词:骨质疏松性骨折多发性硬化症雌激素缺乏OSTEOPOROSISRANKL
雌激素——雌激素受体信号通路对趋化因子的调控作用
雌激素参与机体多项生理、病理调节机制,在机体稳态中发挥不可或缺的作用。趋化因子作为低分子量趋化性细胞因子超家族的一员,活跃于机体各个系统的调节,并且其自身的表达也受到了全身各系统的调控,如内分泌系统的性甾体类固醇激素等。...
许莹萍王菲菲李大金王凌
关键词:雌激素雌激素受体趋化因子
文献传递
雌激素-雌激素受体信号通路对趋化因子的调控作用研究进展被引量:8
2017年
雌激素参与机体多项生理、病理调节机制,在机体稳态中发挥不可或缺的作用。趋化因子作为低分子量趋化性细胞因子超家族的一员,活跃于机体各个系统的调节,并且其自身的表达也受到了全身各系统的调控,如内分泌系统的性甾体类固醇激素等。本文对雌激素-雌激素受体信号通路对趋化因子的调控及其机制作一综述。
许莹萍王菲菲李大金王凌
关键词:雌激素雌激素受体趋化因子
共2页<12>
聚类工具0